LabCompass

Weicang Wang

Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette

Mid career · publishing since 2013Rising activity

Publications

90

Citations

2,117

Est. group size

~6

Recurring co-author estimate

Active years

14

Publishing since 2013

Research summary
AI-generated

Weicang Wang studies how fats and fat-derived signaling molecules (lipids and eicosanoids) affect inflammation and disease, particularly in the gut, liver, heart, and colon cancer. A major focus is an enzyme called soluble epoxide hydrolase (sEH), which breaks down beneficial fatty-acid metabolites, and how blocking it might reduce inflammation, improve immunotherapy outcomes, and protect organs from injury. The work also examines how gut bacteria influence liver and colon health through these same lipid pathways.

Lipid and eicosanoid metabolismSoluble epoxide hydrolase (sEH) inhibitionGut microbiota and gut-liver axisInflammation and cancer immunotherapyColon and liver disease models

Output has fluctuated over the last decade, dipping around 2021-2022 before rebounding to higher activity in 2023 and 2025, suggesting a generally active but variable publication pace.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.2/year recently
2017: 7 publications172018: 10 publications182019: 11 publications192020: 8 publications202021: 2 publications212022: 2 publications222023: 15 publications15232024: 5 publications242025: 10 publications252026: 4 publications26
Recent publications
Publishes in
  • The FASEB Journal×11
  • Journal of Agricultural and Food Chemistry×4
  • Proceedings of the National Academy of Sciences×4
  • The Journal of Nutritional Biochemistry×3
  • Food & Function×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile